Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Catalysis SL
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Masculine \>18 years-old patients
Performans status: Karnofsky ≥ 70 or (ECOG \<2)
Hormonal treatment alternatives 6 or 8 weeks before the inclusion ,with resistence to hormonal treatments
Normal laboratory tests to onco-specific treatments.
Ecocardiogram with a eyección fraction \> 60 %, in patients with history of cardiovascular deseases.
Patients with life expectative more than 6 months.
You may not be if
Patients who are receiving another onco-specific product in research.
Patients with known hypersensitivity to anthracyclines and / or mitoxantrone
Decompensated intercurrent diseases, including: active infections, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, liver damage and psychiatric illnesses that could limit adherence to the requirements of the clinical trial or any other special condition that at the discretion of the physician put your health and life at risk during the study or your participation in the trial.
Patients with cerebral metastases.
Patients with HIV.
Clareo Health | Evaluation of Oncoxin-Viusid® in Prostate Cancer
